Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/74570
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWorawit Louthrenooen_US
dc.contributor.authorNuntana Kasitanonen_US
dc.contributor.authorAntika Wongthaneeen_US
dc.contributor.authorYuko Okudairaen_US
dc.contributor.authorMasumi Takeuchien_US
dc.contributor.authorFumiaki Nakajimaen_US
dc.contributor.authorMiwa Habataen_US
dc.contributor.authorAnri Masuyaen_US
dc.contributor.authorHiroshi Noguchien_US
dc.contributor.authorHidetoshi Inokoen_US
dc.contributor.authorFujio Takeuchien_US
dc.date.accessioned2022-10-16T06:44:38Z-
dc.date.available2022-10-16T06:44:38Z-
dc.date.issued2022-01-01en_US
dc.identifier.issn20592310en_US
dc.identifier.issn20592302en_US
dc.identifier.other2-s2.0-85137845192en_US
dc.identifier.other10.1111/tan.14793en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85137845192&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/74570-
dc.description.abstractHLA studies in patients with systemic sclerosis (SSc) have shown variable results. This study aimed to examine the association of HLA class I and II risk alleles in Thai SSc patients, and clarify the contribution of risk HLA alleles to the pathogenesis and clinical manifestations. Blood samples from 92 SSc patients and 135 healthy controls (HCs) were collected. Eleven loci of the HLA class I (HLA-A, B, and C) and class II (HLA-DR, DP, and DQ) genes were determined by a 3-field (6-digit) analysis using the Next Generation DNA Sequencing (NGS) method. Anti-topoisomerase-I antibodies (ATA) and anti-centromere antibodies (ACA) were identified by ELISA methods. Allele frequencies (AFs) of HLA-DRB1*15:02:01, DRB5*01:02:01, DQB1*05:01:24, DPB1*13:01:01, and DQA1*01:01:01 were increased significantly in the whole SSc and SSc patients with positive ATA, but with negative ACA (SSc/ATA+/ACA−). Of these, DPB1*13:01:01 was the most susceptible allele. The DRB1*15:02:01, DQB1:05:01:24, and DPB1*13:01:01 alleles were estimated to locate on the unique haplotype, and haplotype frequency was estimated to be significantly higher than those in the HCs (p = 0.002). The linkage analysis of DRB1*15/16 revealed that most of the DRB1*15:02:01 alleles were linked to DRB5*01:02:01 or DRB5*01:08:01N. The linkage of DRB1*16:02:01 to DRB5*01:01:01 was observed frequently. The associations of risk alleles with several SSc clinical features were observed. HLA-DRB1*15:02:01, DRB5*01:02:01, DQB1*05:01:24, and DPB1*13:01:01 on the unique haplotype were associated with the pathogenesis and clinical features of SSc in Thai patients. The linkage of DRB1*15:02:01 to DRB5*01:08:01N was observed commonly in northern Thai patients.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleAssociation of HLA-DRB1*15:02:01, DQB1*05:01:24 and DPB1*13:01:01 in Thai patients with systemic sclerosisen_US
dc.typeJournalen_US
article.title.sourcetitleHLAen_US
article.stream.affiliationsFaculty of Medicine, Chiang Mai Universityen_US
article.stream.affiliationsUniversity of Shizuokaen_US
article.stream.affiliationsKobe Universityen_US
article.stream.affiliationsGenoDive Pharma Inc.en_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.